Literature DB >> 27181494

Crouzonodermoskeletal Syndrome with Hypoplasia of Corpus Callosum and Inferior Vermis.

Fatih Gürbüz1, Serdar Ceylaner, Ali Kemal Topaloğlu, Bilgin Yüksel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27181494      PMCID: PMC5096508          DOI: 10.4274/jcrpe.3343

Source DB:  PubMed          Journal:  J Clin Res Pediatr Endocrinol


× No keyword cloud information.

Dear Editor,

Crouzonodermoskeletal syndrome) [Online Mendelian Inheritance in Man (OMIM) ID no. 612247] or Crouzon syndrome with acanthosis nigricans (CSAN) is a clinically and genetically distinct entity from the classic Crouzon syndrome (1). While classic Crouzon syndrome is caused by mutation in the FGFR3 gene, CSAN is caused by only mutation p.A391E in the FGFR3 gene. Other FGFR3 gene mutations are not responsible of this syndrome, and they usually lead to hypochondroplasia or achondroplasia but not CSAN (2,3). Clinically, in addition to classic Crouzon syndrome, patients with CSAN have acanthosis nigricans and skeletal abnormalities (1,4). The phenotypic features include wide-set bulging eyes and underdeveloped upper jaw, craniosynostosis, midface hypoplasia, hypertelorism, proptosis, posteriorly rotated ears, and in some cases, hearing loss. Patients with CSAN often present with choanal atresia and hydrocephalus (4). A ten-month-old girl presented with a facial dysmorphia at birth. There was no consanguinity between her parents. She was born at term weighing 3380 g with no perinatal complications. She had obstructive dyspnea at day 1 due to bilateral choanal atresia for which she was operated at day 9. At 9 months of age, she had coronal craniectomy surgery because of craniosynostosis due to bilateral coronal stenosis. At presentation, her height was 68.7 cm [-1.13 standard deviation score (SDS)] and weight was 7.3 kg (-1.97 SDS). She had atypical facial features (midface hypoplasia, hypertelorism, craniosynostosis, brachycephaly, maxillary hypoplasia, exophthalmos, bilateral distinctive and low-set ears), lateral nystagmus on the bilateral eyes, and widespread acanthosis nigricans on all of curve regions as neck, bilateral axillae (Figure 1). Cranial magnetic resonance imaging (MRI) revealed hydrocephalus, hypoplasia of corpus callosum and inferior vermis (Figure 2). There was no pathology at abdominal ultrasonography and echocardiography. The audiogram did not reveal any pathology. The cognitive and motor development were delayed.
Figure 1

Patient’s facial dysmorphia and widespread acanthosis nigricans on neck and axillae

Figure 2

Patient’s magnetic resonance imaging: presence of hydrocephalus and hypoplasia of corpus callosum and inferior vermis

We detected a de novo heterozygous A391E (c.1172C>A) mutation in FGFR3 gene in our patient. This syndrome is inherited in an autosomal dominant type although most cases are sporadic mutations (5). We detected the mutation in the patient but not in her parents and sisters (Figure 3). Therefore, our patient is a sporadic form of CSAN.
Figure 3

Sight of the patient’s pedigree and sequence (c.1172C>A)

As with other disorders caused by FGFR gene mutations, increased paternal age seems to be a risk factor (1). Our patient’s father age was 42 years old. To our knowledge, this is the first case of CSAN with hypoplasia of corpus callosum and inferior vermis. This association may be coincidental. These patients should be investigated for other possible cranial MRI findings.

Ethics

Peer-review: Internal peer-reviewed.
  5 in total

1.  Recent milestones in achondroplasia research.

Authors:  William A Horton
Journal:  Am J Med Genet A       Date:  2006-01-15       Impact factor: 2.802

2.  A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.

Authors:  D Wilkes; P Rutland; L J Pulleyn; W Reardon; C Moss; J P Ellis; R M Winter; S Malcolm
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

3.  Crouzon syndrome with acanthosis nigricans: a case-based update.

Authors:  Federico Di Rocco; Corinne Collet; Laurence Legeai-Mallet; Eric Arnaud; Martine Le Merrer; Smail Hadj-Rabia; Dominique Renier
Journal:  Childs Nerv Syst       Date:  2010-12-07       Impact factor: 1.475

4.  Crouzon with acanthosis nigricans. Further delineation of the syndrome.

Authors:  L Arnaud-López; R Fragoso; J Mantilla-Capacho; P Barros-Núñez
Journal:  Clin Genet       Date:  2007-11       Impact factor: 4.438

5.  Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.

Authors:  G A Meyers; S J Orlow; I R Munro; K A Przylepa; E W Jabs
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

  5 in total
  1 in total

1.  FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model.

Authors:  Maxence Cornille; Stéphanie Moriceau; Roman H Khonsari; Yann Heuzé; Léa Loisay; Valérie Boitez; Anne Morice; Eric Arnaud; Corinne Collet; Morad Bensidhoum; Nabil Kaci; Nathalie Boddaert; Giovanna Paternoster; Theresa Rauschendorfer; Sabine Werner; Suzanne L Mansour; Federico Di Rocco; Franck Oury; Laurence Legeai-Mallet
Journal:  J Exp Med       Date:  2022-03-07       Impact factor: 17.579

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.